loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Bexotegrast

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Bexotegrast

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Pliant Presents Bexotegrast Data At Respiratory Congress
    Pliant Presents Bexotegrast Data At Respiratory Congress

    10 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/10/2943620/0/en/Pliant-Therapeutics-Presents-Data-from-its-Bexotegrast-Program-at-the-European-Respiratory-Society-International-Congress-2024.html

    GLOBENEWSWIRE
    10 Sep 2024
    Share Share
    Pliant Reports Positive Long-Term Data From INTEGRIS-PSC Phase 2a Trial
    Pliant Reports Positive Long-Term Data From INTEGRIS-PSC Phase 2a Trial

    15 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/15/2912994/0/en/Pliant-Therapeutics-Announces-Positive-Long-Term-Data-from-the-INTEGRIS-PSC-Phase-2a-Trial-Demonstrating-Bexotegrast-was-Well-Tolerated-at-320-mg-with-Continued-Antifibrotic-and-An.html

    GLOBENEWSWIRE
    15 Jul 2024
    Share Share
    Pliant Presents Data From Bexotegrast Program At EASL International Congress
    Pliant Presents Data From Bexotegrast Program At EASL International Congress

    06 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/06/2894591/0/en/Pliant-Therapeutics-Presents-Data-from-its-Bexotegrast-Program-at-the-European-Association-for-the-Study-of-the-Liver-EASL-International-Liver-Congress.html

    GLOBENEWSWIRE
    06 Jun 2024
    Share Share
    Pliant Presents Bexotegrast Data At American Thoracic Society Conference
    Pliant Presents Bexotegrast Data At American Thoracic Society Conference

    21 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/21/2886108/0/en/Pliant-Therapeutics-Presents-Data-from-its-Bexotegrast-Program-at-the-American-Thoracic-Society-International-Conference.html

    GLOBENEWSWIRE
    21 May 2024
    Share Share
    Pliant Announces Positive Phase 2a Bexotegrast IPF Imaging Data
    Pliant Announces Positive Phase 2a Bexotegrast IPF Imaging Data

    14 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/14/2881271/0/en/Pliant-Therapeutics-Announces-Positive-Topline-Data-from-a-Phase-2a-Collagen-PET-Imaging-Clinical-Trial-of-Bexotegrast-in-Patients-with-Idiopathic-Pulmonary-Fibrosis.html

    GLOBENEWSWIRE
    14 May 2024
    Share Share
    Pliant Therapeutics Announces Accelerated Bexotegrast Development Plan
    Pliant Therapeutics Announces Accelerated Bexotegrast Development Plan

    12 Mar 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/03/12/2844430/0/en/Pliant-Therapeutics-Announces-Accelerated-Bexotegrast-Development-Plan-for-the-Treatment-of-Idiopathic-Pulmonary-Fibrosis.html

    GLOBENEWSWIRE
    12 Mar 2024
    Share Share